Hussein Tawbi

DEVELOPMENT OF A FIVE-GENE HEDGEHOG SIGNATURE AS A PATIENT PRESELECTION TOOL FOR HEDGEHOG PATHWAY-TARGETED THERAPY IN MEDULLOBLASTOMA

Keith L. Ligon, Douglas Robinson, Jordi Rodon, 2013 .

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

Hussein Tawbi, Aliya N. Husain, L. Heinzerling, 2016, Journal of Immunotherapy for Cancer.

Chordoma: the nonsarcoma primary bone tumor.

Scott M Schuetze, Laurence H Baker, David R Lucas, 2007, The oncologist.